Home
>
US Stocks
>
Aclaris Therapeutics Inc
Aclaris Therapeutics Inc
ACRS

Aclaris Therapeutics Inc

$16.5415.75%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
16.98
Today Low/High
16.48 / 16.98
52 Week Low/High
$1.98 / $30.38
P/E ratio
-11.5861
Market Cap
$819.68M

Company Details

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
Organisation
Aclaris Therapeutics Inc
Headquaters
Wayne, Pennsylvania, US
Employees
59
Industry
Health Technology
CEO
Neal Walker

Discover more

Frequently Asked Questions

What is Aclaris Therapeutics Inc share price today

Can Indians buy Aclaris Therapeutics Inc shares?

How can I buy Aclaris Therapeutics Inc shares from India?

Can Fractional shares of Aclaris Therapeutics Inc be purchased?

What are the documents required to start investing in Aclaris Therapeutics Inc stocks?

We are a SEBI registered investement advisor